Nureca Limited - Asset Resilience Ratio

Latest as of September 2025: 3.36%

Nureca Limited (NURECA) has an Asset Resilience Ratio of 3.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check NURECA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs75.48 Million

≈ $816.29K USD Cash + Short-term Investments

Total Assets

Rs2.25 Billion

≈ $24.30 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Nureca Limited's Asset Resilience Ratio has changed over time. See Nureca Limited balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Nureca Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Nureca Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs75.48 Million	3.36%
Total Liquid Assets	Rs75.48 Million	3.36%

Asset Resilience Insights

Limited Liquidity: Nureca Limited maintains only 3.36% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Nureca Limited Industry Peers by Asset Resilience Ratio

Compare Nureca Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for Nureca Limited (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Nureca Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	33.52%	Rs703.88 Million ≈ $7.61 Million	Rs2.10 Billion ≈ $22.71 Million	-29.76pp
2024-03-31	63.28%	Rs1.30 Billion ≈ $14.04 Million	Rs2.05 Billion ≈ $22.19 Million	+14.12pp
2023-03-31	49.16%	Rs1.02 Billion ≈ $10.98 Million	Rs2.07 Billion ≈ $22.34 Million	+10.62pp
2022-03-31	38.54%	Rs844.61 Million ≈ $9.13 Million	Rs2.19 Billion ≈ $23.70 Million	+1.64pp
2021-03-31	36.90%	Rs685.50 Million ≈ $7.41 Million	Rs1.86 Billion ≈ $20.09 Million	--

pp = percentage points

About Nureca Limited

NSE:NURECA India Medical Devices

Market Cap

$24.65 Million

Rs2.28 Billion INR

Market Cap Rank

#24449 Global

#1347 in India

Share Price

Rs238.85

Change (1 day)

-0.08%

52-Week Range

Rs206.75 - Rs332.62

All Time High

Rs2117.13